all report title image

BLOOD COLLECTION TUBES MARKET ANALYSIS

Blood Collection Tubes Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028

  • To Be Published : Dec 2024
  • Code : CMI420
  • Formats :
      Excel and PDF
  • Industry : Medical Devices

Market News

Key Developments

  • For instance, in January 2020, Biodesix Inc., entered into a partnership with Streck Inc., in order to combine Next generation Sequencing (NGS) and Droplet Digital PCR (ddPCR) diagnostics for the development of blood-based tumor profiling. Under this collaboration, blood collection tubes and preservatives of Streck Inc. and the sample collection protocols of the Biodesix Inc. can be combined. Thus, the blood-based tumor profiling will be available as the first line treatments, which will help to overcome the tissue-based tests currently available in the market.
  • In 2016, Becton, Dickinson and Company, received the U.S. Food and Drug Administration, (U.S. FDA), approval for its vaccutainer Barricor plasma blood collection tube. This tube is a, single use, plastic evacuated tube having benefits separating plasma within three minutes of centrifugation, as compared to the conventional blood collection tubes that require at least 10 minutes of centrifugation.
  • In November 2019, Biocept received CE mark for its CEE-sure blood collection tube and CEE-sure sample collection shipping kit. The blood collection tube can be used for collection of (circulating tumor cell) CTCs, cytoplasmic DNA (ctDNA), ctRNA for NGS. It can also be used for collection of blood, cerebrospinal fluid, fluid from pleural effusion, and sputum.
  • In September 2019, Roche received the U.S. FDA approval for its Cobas Babesia test for use on the Cobas 6800/8800 systems for individual blood testing. The contents in the blood can be checked in the collection tubes, which simplifies the sample preparation process as the sample preparation steps are combined within the tube itself to provide an efficient solution for testing laboratories.
  • Key players are focusing on adopting inorganic growth strategies such as collaborations, in order to enhance their product portfolio. For instance, in November 2019, Qiagen and DiaSorin collaborated to launch the QuantiFERON-TB plus (QFT-plus) for detection of latent tuberculosis detection. The collaboration allowed combination of Qiagen standard QuantiFERON-TB Gold-Plus Blood Collection Tube with DiaSorin’s LIAISON QuantiFERON-TB plus detection assay.
  • A wide range of Vacuette blood collection tubes are offered by Greiner Bio-One. Since, the tubes are vacuum tubes having the back flow of the blood which is being prevented during blood collection process.

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.